E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/11/2007 in the Prospect News Convertibles Daily.

Sharon Bio-Medicine may issue up to Rs. 5 billion in convertibles

By Devika Patel

Knoxville, Tenn., Dec. 11 - Sharon Bio-Medicine Ltd. informed the Bombay Stock Exchange that it will consider plans to issue up to Rs. 5 billion in convertible bonds at an annual general meeting on Dec. 31.

Sharon Bio-Medicine is a Mumbai, India-based pharmaceutical company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.